Literature DB >> 12545552

Adeno-associated virus vectors for therapeutic gene transfer.

Jackie L Stilwell1, R Jude Samulski.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12545552     DOI: 10.2144/03341dd01

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


× No keyword cloud information.
  17 in total

1.  Systemic protein delivery by muscle-gene transfer is limited by a local immune response.

Authors:  Lixin Wang; Eric Dobrzynski; Alexander Schlachterman; Ou Cao; Roland W Herzog
Journal:  Blood       Date:  2005-02-15       Impact factor: 22.113

Review 2.  Gene therapy for type 1 diabetes: is it ready for the clinic?

Authors:  Antonella D'Anneo; Pleunie Rood; Rita Bottino; A N Balamurugan; Jing He; Nick Giannoukakis
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization.

Authors:  Michael A Lochrie; Gwen P Tatsuno; Brian Christie; Jennifer Wellman McDonnell; Shangzhen Zhou; Richard Surosky; Glenn F Pierce; Peter Colosi
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 4.  Adeno-associated virus vectors: potential applications for cancer gene therapy.

Authors:  Chengwen Li; Dawn E Bowles; Terry van Dyke; Richard Jude Samulski
Journal:  Cancer Gene Ther       Date:  2005-12       Impact factor: 5.987

5.  Delivery of MDR1 small interfering RNA by self-complementary recombinant adeno-associated virus vector.

Authors:  Dong Xu; Doug McCarty; Alda Fernandes; Michael Fisher; R J Samulski; R L Juliano
Journal:  Mol Ther       Date:  2005-04       Impact factor: 11.454

6.  Gene and cell therapy based treatment strategies for inflammatory bowel diseases.

Authors:  Sander van der Marel; Anna Majowicz; Sander van Deventer; Harald Petry; Daniel W Hommes; Valerie Ferreira
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

Review 7.  The complex and evolving story of T cell activation to AAV vector-encoded transgene products.

Authors:  Lauren E Mays; James M Wilson
Journal:  Mol Ther       Date:  2010-11-30       Impact factor: 11.454

8.  A nonproliferating parvovirus vaccine vector elicits sustained, protective humoral immunity following a single intravenous or intranasal inoculation.

Authors:  Gene A Palmer; Jennifer L Brogdon; Stephanie L Constant; Peter Tattersall
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Effect of small interference RNA targeting HIF-1alpha mediated by rAAV combined L: -ascorbate on pancreatic tumors in athymic mice.

Authors:  Chuangui Chen; Jinjin Sun; Geng Liu; Jianqiu Chen
Journal:  Pathol Oncol Res       Date:  2008-05-29       Impact factor: 3.201

10.  Gene delivery to intestinal epithelial cells in vitro and in vivo with recombinant adeno-associated virus types 1, 2 and 5.

Authors:  Steven Polyak; Cathryn Mah; Stacy Porvasnik; John-David Herlihy; Martha Campbell-Thompson; Barry J Byrne; John F Valentine
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.